Sign In
Buy SUEZF
Sudzucker AG. Earnings Calls
| Release date | Jul 09, 2026 |
| EPS estimate | - |
| EPS actual | -$0.0117 |
| Revenue estimate | 2.398B |
| Revenue actual | 2.399B |
| Revenue Surprise | 0.0632% |
| Release date | May 21, 2026 |
| EPS estimate | - |
| EPS actual | -$1.80 |
| Revenue estimate | 2.439B |
| Revenue actual | 2.359B |
| Revenue Surprise | -3.29% |
| Release date | Jan 13, 2026 |
| EPS estimate | -$0.0232 |
| EPS actual | -$0.0232 |
| Revenue estimate | 2.564B |
| Revenue actual | 2.5B |
| Revenue Surprise | -2.47% |
| Release date | Oct 09, 2025 |
| EPS estimate | - |
| EPS actual | -$0.234 |
| Revenue estimate | 2.463B |
| Revenue actual | 2.395B |
| Revenue Surprise | -2.73% |
Last 4 Quarters for Sudzucker AG.
Below you can see how SUEZF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Oct 09, 2025 |
| Price on release | $13.00 |
| EPS estimate | - |
| EPS actual | -$0.234 |
| Date | Price |
|---|---|
| Oct 03, 2025 | $13.00 |
| Oct 06, 2025 | $13.00 |
| Oct 07, 2025 | $13.00 |
| Oct 08, 2025 | $13.00 |
| Oct 09, 2025 | $13.00 |
| Oct 10, 2025 | $13.00 |
| Oct 13, 2025 | $13.00 |
| Oct 14, 2025 | $13.00 |
| Oct 15, 2025 | $13.00 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
| Release date | Jan 13, 2026 |
| Price on release | $10.77 |
| EPS estimate | -$0.0232 |
| EPS actual | -$0.0232 |
| Date | Price |
|---|---|
| Jan 07, 2026 | $10.77 |
| Jan 08, 2026 | $10.77 |
| Jan 09, 2026 | $10.77 |
| Jan 12, 2026 | $13.00 |
| Jan 13, 2026 | $10.77 |
| Jan 14, 2026 | $10.77 |
| Jan 15, 2026 | $10.77 |
| Jan 16, 2026 | $13.00 |
| Jan 20, 2026 | $10.77 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
| Release date | May 21, 2026 |
| Price on release | $12.02 |
| EPS estimate | - |
| EPS actual | -$1.80 |
| Date | Price |
|---|---|
| May 15, 2026 | $12.02 |
| May 18, 2026 | $12.02 |
| May 19, 2026 | $12.02 |
| May 20, 2026 | $12.02 |
| May 21, 2026 | $12.02 |
| May 22, 2026 | $11.99 |
| May 26, 2026 | $12.02 |
| May 27, 2026 | $12.02 |
| May 28, 2026 | $12.02 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | -0.266% |
| Change in period | 0% |
| Release date | Jul 09, 2026 |
| Price on release | $11.99 |
| EPS estimate | - |
| EPS actual | -$0.0117 |
| Date | Price |
|---|---|
| Jul 02, 2026 | $11.99 |
| Jul 06, 2026 | $11.99 |
| Jul 07, 2026 | $11.99 |
| Jul 08, 2026 | $11.99 |
| Jul 09, 2026 | $11.99 |
| Jul 10, 2026 | $11.99 |
| Jul 13, 2026 | $11.99 |
| Jul 14, 2026 | $11.99 |
| Jul 15, 2026 | $11.99 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
Sudzucker AG. Earnings Call Transcript Summary of Q2 2026
Südzucker reported a weak H1 for FY 2025/26: group revenues (~€4.2bn), EBITDA (€189m, -55%) and operating profit (€42m vs €269m prior year) declined significantly. The sugar segment was the main drag (H1 operating loss €89m vs prior year profit €72m) amid a bearish global and European sugar market (expected surplus in 2025/26, falling EU reference prices, and potential increased duty‑free imports from Ukraine). CropEnergies and starch also saw weaker H1 results (CropEnergies loss from technical downtime and lower ethanol prices; ethanol prices have recently rebounded). Offsetting strengths: fruit, BENEO and Freiberger performed well. Management confirmed the revised full‑year guidance (announced Aug 21): revenues €8.3–8.7bn, EBITDA €470–570m, operating profit €100–200m (prior guidance was €150–300m). They also outlined cost savings targets: €200m total (≈€100m sugar, €100m nonsugar) with ~€80m targeted to materialize in this fiscal year as actions ramp up (programs OPTIMUM and NEXT LEVEL). Financial position: net financial debt ~€1.67bn (stable vs FY end), equity ratio 45%; refinancing completed (€700m hybrid, €500m senior bond, extended €800m syndicated loan). Management targets net debt/EBITDA <3.5x and remains committed to achieving/retaining investment‑grade rating. Key risks: continued weak sugar prices, volatility from geopolitics and FX, possible additional one‑offs, uncertainty over Ensus (UK ethanol plant) government support, and commodity/hedging impacts on starch.
